English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduIt can be hard to know that you have glaucoma. In a study carried out at the University of Gothenburg, almost five percent of 70-year-olds were found to have glaucoma, and half of those diagnosed were unaware that they had the disease.
Tag: Glaucoma
The Medical Minute: Early detection key to protecting vision from glaucoma
Glaucoma can develop for years before you experience a symptom. A Penn State Health optometrist discusses early diagnosis and how testing can make all the difference for your vision.
Patients With Specific Types of Lipids May Be at Higher Risk of Developing Blinding Eye Disease
Principal Investigator: Louis R. Pasquale, MD, FARVO, Deputy Chair for Ophthalmology Research for the Mount Sinai Health System Co-First Authors: Oana A. Zeleznik, PhD, Instructor in Medicine at Brigham and Women’s Hospital and Jae H. Kang, ScD, Assistant Professor of…
AI Used to Advance Drug Delivery System for Glaucoma and Other Chronic Diseases
Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells.
King Chulalongkorn Memorial Hospital Doctors Suggest Ways to Prevent Glaucoma through Early Detection
The Excellence Center for Glaucoma, Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, and Thai Glaucoma Society encourage all of us to realize the significance of glaucoma as it is the world’s number 1 cause of irreversible blindness. In Thailand, over 2 million people are affected by glaucoma.
Vision Research Funding Partnership Event Takes Place Today
Today, Research to Prevent Blindness (RPB) and more than 30 other organizations are convening in Washington DC for the Vision Research Funding Partnership event, which was organized around the theme of “The Research Pipeline – From Premise to Patient.”
Glaucoma Research Foundation Awards 2023 Shaffer Prize to Dr. Rachel Wang Kuchtey (Vanderbilt) and Dr. Lev Prasov (University of Michigan)
The 2023 Shaffer Prize for Innovative Glaucoma Research recognizes two Shaffer Grant recipients whose projects best exemplify the pursuit of breakthrough ideas in the quest to better understand and cure glaucoma.
Smart contact lens that diagnoses and treats glaucoma
Glaucoma is a common ocular disease in which the optic nerve malfunctions due to the increased intraocular pressure (IOP) caused by drainage canal blocking in the eye.
ARVO Foundation Names 2023 Winners of Dr. David L. Epstein Award
The Association for Research in Vision and Ophthalmology (ARVO) announced today the 2023 recipients of the Dr. David L. Epstein Award:Since 2016, the Dr. David L. Epstein Award has been given annually to a well-established senior investigator with a documented history of conducting eye and vision research in glaucoma and of mentoring clinician-scientists to independent academic and research careers.
ARVO Foundation Announces Recipients of 2023 Pfizer Ophthalmics Carl Camras Translational Research Award
The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today the recipients of the 2023 Pfizer Ophthalmics Carl Camras Translational Research Award:Granted annually to young investigators working in areas of translational research, each recipient will be awarded $12,000.
Bausch + Lomb and Glaucoma Research Foundation Announce Launch of Screen, Protect, Cure Campaign In Recognition of Glaucoma Awareness Month
Bausch + Lomb, a leading global eye health company, and Glaucoma Research Foundation a non-profit organization with the vision of curing glaucoma, today announced the launch of ‘Screen, Protect, Cure,’ a campaign designed to provide educational resources and raise awareness of glaucoma.
Research to Prevent Blindness Marks $400 Million in Funding to Advance Eye Disease Research
Research to Prevent Blindness announces a new round of awardees who are generating critical knowledge around a host of sight-threatening conditions. With this latest round of funding, RPB has provided more than $400 million in research funding.
UC Davis Health opens doors to new state-of-the-art eye care facility in Sacramento
UC Davis Health welcomed the first patients to the new Ernest E. Tschannen Eye Institute on Monday, Dec. 5. The state-of-the-art facility, which houses both clinicians and researchers, is dedicated to advancing world-class eye care and offering hope for sight restoration.
New Genetic Mutation Behind Childhood Glaucoma Identified
An international team of researchers led by Mass Eye and Ear discovered a new genetic mutation that leads to childhood glaucoma, and in the process uncovered a new mechanism for causing the disease.
3D map reveals DNA organization within human retina cells
National Eye Institute researchers mapped the organization of human retinal cell chromatin, the fibers that package 3 billion nucleotide-long DNA molecules into compact structures that fit into chromosomes within each cell’s nucleus. The resulting comprehensive gene regulatory network provides insights into regulation of gene expression in general, and in retinal function, in both rare and common eye diseases. The study published in Nature Communications.
Right Combination of Vitamins May Help Prevent Glaucoma
Researchers found that people who consumed high amounts of vitamins A, C, and E, either as supplements or through food, were 47 percent less likely to develop glaucoma.
New Study Shows People with Glaucoma are at Significant Risk of Alzheimer’s Disease
A large, nationwide study from Taiwan shows that people with normal-tension glaucoma are at high risk for developing Alzheimer’s disease.
Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2023 Recipient of RPB David F. Weeks Award for Outstanding Vision Research
David J. Calkins, PhD, has been selected as the 2023 RPB David F. Weeks Award for Outstanding Vision Research.
Early onset of diabetes, hypertension can predict early glaucoma, UTSW ophthalmologists report
The earlier individuals develop Type 2 diabetes or hypertension in life, the earlier they are likely to develop primary open-angle glaucoma (POAG), the leading cause of irreversible blindness worldwide, researchers from UT Southwestern reported in a recent study. The findings, published in Clinical Ophthalmology, could lead to better screening protocols for POAG, which accounts for up to 90% of all cases of glaucoma.
Scientists Uncover Role of Alzheimer’s-Linked APOE Gene in Glaucoma Protection and Identify Promising Treatment Strategy to Prevent Vision Loss
Scientists have demonstrated that the APOE4 gene variant, which increases risk for Alzheimer’s but decreases risk of glaucoma in humans, blocks a disease cascade that leads to the destruction of retinal ganglion cells in glaucoma. Additionally, they showed in mouse models that the death of retinal ganglion cells – the cause of vision loss in glaucoma – can be prevented by using medications to inhibit a molecule called Galectin-3, which is regulated by the APOE gene. These findings taken together emphasize the critical role of APOE in glaucoma and suggest that Galectin-3 inhibitors hold promise as a glaucoma treatment, according to the authors.
“Solving Neurodegeneration” White Paper Publication Results from Innovative Research Collaboration
The findings from the meeting were recently published in Molecular Neurodegeneration and raise opportunities for new treatments and cures for neurodegenerative diseases like glaucoma and Alzheimer’s.
High-Tech Imaging Offers New Way to Detect Signs of Early Glaucoma
Mount Sinai study shows flavoprotein fluorescence could serve as new biomarker
Black Patients Found Six Times More Likely to Have Advanced Vision Loss After Glaucoma Diagnosis Than White Patients
Black patients have a dramatically higher risk of advanced vision loss after a new diagnosis of primary open angle glaucoma (POAG) when compared to white patients, according to a new study from New York Eye and Ear Infirmary of Mount Sinai (NYEE).
Glaucoma Research Foundation Launches Catalyst For A Cure Initiative to Prevent and Cure Neurodegeneration
The Neurodegeneration Initiative was launched through a transformative $2.4 million gift to Glaucoma Research Foundation from the Melza M. and Frank Theodore Barr Foundation.
RUDN doctors proposed a new method of glaucoma treatment
RUDN University doctors have proposed an alternative method of surgical management of glaucoma. The main risk factor of glaucoma is increased pressure in the eye. To reduce it doctors proposed to remove excess fluid from the eye in a new way. The first clinical trials show the success of the technique.
Home IOP Measurements: What they can tell us
Understanding how your IOP (intraocular pressure) changes over time can help you and your doctor feel confident that your glaucoma treatment is working effectively.
Noninvasive Eye Procedure Provides Potential Pathway for Virus, Disease Carriers
In Physics of Fluids, by AIP Publishing, scientists from the Indian Institute of Science and the Narayana Nethralaya Foundation explain how tears ejected from the eye during a procedure that tests for glaucoma can theoretically transmit disease.
UIC researchers find evidence of possible link between herpes simplex and neurogenerative diseases
A new study by researchers at University of Illinois Chicago suggests that when the protein optineurin, or OPTN, is present in cells it restricts the spread of HSV-1, the herpes simplex virus type 1.In a “first of its kind” study, researchers also found a potential direct connection between neurodegenerative diseases, such as Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), glaucoma, and the herpesvirus.
Research to Prevent Blindness and American Academy of Ophthalmology Award Grants for Big Data Research to Improve Patient Care
The American Academy of Ophthalmology and Research to Prevent Blindness (RPB) today announced the recipients of the Research to Prevent Blindness/American Academy of Ophthalmology Award for IRIS® Registry Research.
Glaucoma Research Foundation Receives $1.5 million Gift For Collaborative Vision Restoration Initiative
The Kirsch gift will be a matching opportunity to inspire other donors to support this groundbreaking research to restore vision lost due to glaucoma.
Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2022 Recipient of RPB David F. Weeks Award for Outstanding Vision Research
Donald Zack, MD, PhD, is recognized for ground-breaking contributions to the field of vision research, funded by Research to Prevent Blindness, an anonymous donor, and the Association of University Professors of Ophthalmology.
The Second Annual TGF Art Challenge to Celebrate Vision
This summer, enjoy celebrating art while you double the impact of your contribution to glaucoma research.
High Caffeine Consumption may be Associated with Increased Risk of Blinding Eye Disease
Frequent caffeine intake could more than triple risk of glaucoma for those genetically predisposed to higher eye pressure
Research to Prevent Blindness and The Glaucoma Foundation Offer Critical Funding for Early-Career Vision Scientists
Research to Prevent Blindness and The Glaucoma Foundation are pleased to announce a new round of grants, the Career Advancement Awards (CAAs), that support early-career researchers as they seek new knowledge related to eye diseases.
New Fellowships Support Under-Represented Minorities in Glaucoma Research
The Glaucoma Foundation (TGF) and Research to Prevent Blindness (RPB) have partnered to launch a new grant aimed at supporting under-represented racial and ethnic minority researchers in the pursuit of glaucoma research. The TGF (sponsored by Patricia Hill) / RPB Fellowships in Glaucoma provide one-year, $10,000 fellowships focused on substantive glaucoma research.
Glaucoma Research Foundation Announces $1.7 Million in 2021 Research Grants
Glaucoma Research Foundation (GRF) today announced a total of $1.7 million in annual research grants to support 13 investigators at prestigious colleges and universities across the United States.
International Team Identifies 127 Glaucoma Genes in Largest Study of Its Kind
In the largest genome-wide association study of glaucoma to date, an international team of researchers compared the genes of 34,179 people with the disease to 349,321 control subjects. They identified 127 genes linked to glaucoma, including 44 new gene loci and confirmed 83 previously reported loci.
Bringing the Latest Glaucoma Science Directly to the Patient
Four brief, illuminating talks by experts on gene therapy, optic nerve regeneration, the role of artificial intelligence, and the importance of trust between physician and patient.
Glaucoma Research Foundation Awards 2021 Shaffer Prize to Pete Williams, PhD
For his research project studying neuroprotection in glaucoma, Pete Williams, PhD from the Karolinska Institutet in Stockholm was awarded the 2021 Shaffer Prize for Innovative Glaucoma Research.
Glaucoma Research Foundation Releases Video Encouraging Patients to Visit Their Eye Doctor for the Care They Need During COVID-19 Pandemic
The COVID-19 pandemic has presented many challenges including delayed eye doctor appointments. This video will discuss changes eye doctors have made to improve safety during every step of the office visit.
Researchers Discover Clue to How to Protect Neurons and Encourage Their Growth
Researchers have identified a family of enzymes whose inhibition both protects neurons and encourages their growth, a pathway to potential new treatments for neurodegenerative diseases from Alzheimer’s to glaucoma.
Research Finds Little Progress on Worldwide Blindness in a Decade
Sobering new statistics released by the Global Burden of Disease study found no significant reduction in the number of people with treatable sight loss worldwide since 2010 as public health services failed to meet World Health Organization (WHO) targets.
Three Mount Sinai Ophthalmologists Receive Prestigious Achievement Awards
Multiple honors recognize leadership and exemplary scientific and educational contributions
Weighing Risks and Benefits for Glaucoma Patients During COVID-19
Michigan Medicine ophthalmologists create a scalable algorithm for triaging appointments during the pandemic.
New York Eye and Ear Infirmary of Mount Sinai Celebrates 200th Anniversary and Honors its Pioneering Black Physician
Hosts Dedication for a Former Slave Who Became Country’s First African American Eye and Ear Specialist
Researchers Discover Stem Cells in Optic Nerve that Preserve Vision
Researchers at the University of Maryland School of Medicine (UMSOM) have for the first time identified stem cells in the region of the optic nerve, which transmits signals from the eye to the brain. The finding presents a new theory on why the most common form of glaucoma may develop and potential for new therapies.
Low-Carbohydrate Diet May Be Associated With Lower Risk of Blinding Eye Disease
Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may lower the risk of the most common subtype of glaucoma
National Glaucoma Research Foundation Survey Reveals Glaucoma Patients’ Experiences and Concerns During COVID-19 Pandemic
National survey finds appointment delays and cancellations were the greatest cause of concern; waiting for in-person appointments is greatly preferred over telemedicine.
Exercise can slow or prevent vision loss, study finds
Exercise can slow or prevent the development of macular degeneration and may benefit other common causes of vision loss, such as glaucoma and diabetic retinopathy, new research suggests.
Star-Shaped Brain Cells May Play a Critical Role in Glaucoma
After a brain injury, cells that normally nourish nerves may actually kill them instead, a new study in rodents finds. This “reactive” phenomenon may be the driving factor behind neurodegenerative diseases like glaucoma, a leading cause of blindness.